Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
AMICUS THERAPEUTICS, INC. (FOLD)
|
|
| Common Size Income Statement |
|
|
|
|
Annual | Quarterly | TTM |
|
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
| Revenues | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| Cost of goods sold | 11.7% | 11.3% | 11.9% | 12.1% | 15.8% | 16.9% | 16.8% | |
| Gross profit | 88.3% | 88.7% | 88.1% | 87.9% | 84.2% | 83.1% | 83.2% | |
| Selling, general and administrative | 64.7% | 63.1% | 60.0% | 93.2% | 139.4% | 240.1% | 1435.1% | |
| Research and development | 84.0% | 89.0% | 118.2% | 157.1% | 296.9% | 404.3% | 2113.6% | |
| General and administrative | | | | | | | | |
| EBITDA | -60.5% | -63.4% | -90.1% | -162.4% | -352.1% | -561.3% | -3465.5% | |
| Depreciation | 1.6% | 2.0% | 3.4% | 2.6% | 4.6% | 9.7% | 65.4% | |
| EBIT | -62.1% | -65.4% | -93.5% | -165.0% | -356.7% | -571.0% | -3530.9% | |
| Pre-tax income | -73.5% | -79.1% | -105.1% | -195.3% | -382.6% | -1216.1% | -4110.1% | |
| Income taxes | -1.7% | 2.9% | 1.0% | 0.3% | -0.1% | -447.1% | -75.4% | |
| Net income | -71.9% | -82.0% | -106.1% | -195.6% | -382.5% | -769.0% | -4034.7% | |
|